An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Curran, 2011, Sequential vs concurrent chemoradiation for stage III non–small-cell lung cancer: randomized phase III trial RTOG 9410, J Natl Cancer Inst, 103, 1452, 10.1093/jnci/djr325
Albain, 2009, Radiotherapy plus chemotherapy with or without surgical resection for stage III non–small-cell lung cancer: a phase III randomised controlled trial, Lancet, 374, 379, 10.1016/S0140-6736(09)60737-6
Grossi, 2010, Future scenarios for the treatment of advanced non–small-cell lung cancer: focus on taxane-containing regimens, Oncologist, 15, 1102, 10.1634/theoncologist.2010-0322
Ettinger, 2013, Non-small cell lung cancer, version 2.2013, J Natl Compr Canc Netw, 11, 645, 10.6004/jnccn.2013.0084
Gerber, 2013, Maintenance chemotherapy for advanced non–small-cell lung cancer: new life for an old idea, J Clin Oncol, 31, 1009, 10.1200/JCO.2012.43.7459
Maemondo, 2010, Gefitinib or chemotherapy for non–small-cell lung cancer with mutated EGFR, N Engl J Med, 362, 2380, 10.1056/NEJMoa0909530
Weichselbaum, 2011, Oligometastases revisited, Nat Rev Clin Oncol, 8, 378, 10.1038/nrclinonc.2011.44
Mehta, 2004, Analysis of further disease progression in metastatic non–small-cell lung cancer: implications for locoregional treatment, Int J Oncol, 25, 1677
Rusthoven, 2009, Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis, Acta Oncol, 48, 578, 10.1080/02841860802662722
Villarreal-Garza, 2013, Aggressive treatment of primary tumor in patients with non–small-cell lung cancer and exclusively brain metastases, Clin Lung Cancer, 14, 6, 10.1016/j.cllc.2012.05.002
Pfannschmidt, 2010, Surgical treatment of oligometastatic non–small-cell lung cancer, Lung Cancer, 69, 251, 10.1016/j.lungcan.2010.05.003
Milano, 2012, Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study, Int J Radiat Oncol Biol Phys, 83, 878, 10.1016/j.ijrobp.2011.08.036
De Ruysscher, 2012, Radical treatment of non–small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (NCT01282450), J Thorac Oncol, 7, 1547, 10.1097/JTO.0b013e318262caf6
Hasselle, 2012, Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non–small-cell lung cancer, J Thorac Oncol, 7, 376, 10.1097/JTO.0b013e31824166a5
Ashworth, 2013, Is there an oligometastatic state in NSCLC? A systematic review of the literature, Lung Cancer, 82, 197, 10.1016/j.lungcan.2013.07.026
Onishi, 2004, Stereotactic hypofractionated high-dose irradiation for stage I non–small-cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multi-institutional study, Cancer, 101, 1623, 10.1002/cncr.20539
Palma, 2012, Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial, BMC Cancer, 12, 305, 10.1186/1471-2407-12-305
Daniels, 2005, Complete resection of non–small-cell lung cancer and oligo-metastatic brain disease, Aust N Z J Surg, 75, 963, 10.1111/j.1445-2197.2005.03585.x
De Pas, 2007, Oligometastatic non–small-cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era, Ann Thorac Surg, 83, 231, 10.1016/j.athoracsur.2006.08.017
Kim, 2010, Results and prognostic factors of hypofractionated stereotactic radiation therapy for primary or metastatic lung cancer, J Thorac Oncol, 5, 526, 10.1097/JTO.0b013e3181cbf622
Lo, 2010, Surgical management of primary non–small-cell carcinoma of lung with synchronous solitary brain metastasis: local experience, Hong Kong Med J, 16, 186
Lopez Guerra, 2012, Prognostic impact of radiation therapy to the primary tumor in patients with non–small-cell lung cancer and oligometastasis at diagnosis, Int J Radiat Oncol Biol Phys, 84, e61, 10.1016/j.ijrobp.2012.02.054
Lucchi, 2005, Metachronous adrenal masses in resected non–small-cell lung cancer patients: therapeutic implications of laparoscopic adrenalectomy, Eur J Cardiothorac Surg, 27, 753, 10.1016/j.ejcts.2005.01.047
Melloni, 2011, Combined treatment of non–small-cell lung cancer with synchronous brain metastases: a single center experience, J Cardiovasc Surg, 52, 613
Mercier, 2005, Surgical treatment of solitary adrenal metastasis from non–small-cell lung cancer, J Thorac Cardiovasc Surg, 130, 136, 10.1016/j.jtcvs.2004.09.020
Mordant, 2012, Which metastasis management allows long-term survival of synchronous solitary M1b non–small-cell lung cancer?, Eur J Cardiothorac Surg, 41, 617, 10.1093/ejcts/ezr042
Popovic, 1993, Craniotomy and thoracotomy for non–small-cell carcinoma of the lung with cerebral metastasis, Aust N Z J Surg, 63, 341, 10.1111/j.1445-2197.1993.tb00399.x
Porte, 2001, Resection of adrenal metastases from non–small-cell lung cancer: a multicenter study, Ann Thorac Surg, 71, 981, 10.1016/S0003-4975(00)02509-1
Ricardi, 2012, Stereotactic body radiation therapy for lung metastases, Lung Cancer, 75, 77, 10.1016/j.lungcan.2011.04.021
Salah, 2012, Metastatectomy for extra-cranial extra-adrenal non–small-cell lung cancer solitary metastases: systematic review and analysis of reported cases, Lung Cancer, 75, 9, 10.1016/j.lungcan.2011.07.014
Scorsetti, 2012, Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34 patients, Acta Oncologica, 51, 618, 10.3109/0284186X.2011.652738
Lei, 2012, A prospective investigation of definitive targeted therapy for solid malignancies with oligometastases, Int J Radiat Oncol Biol Phys, 84, 6, 10.1016/j.ijrobp.2012.07.1687
Griffioen, 2013, Radical treatment of synchronous oligometastatic non–small-cell lung carcinoma (NSCLC): patient outcomes and prognostic factors, Lung Cancer, 82, 95, 10.1016/j.lungcan.2013.07.023
Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2010. National Cancer Institute, Bethesda, MD, 2012, posted to the SEER web site, 2013, based on November 2012 SEER data submission, Available at: http://seer.cancer.gov/csr/1975_2011/. Accessed: October 15, 2013.
Rami-Porta, 2009, The revised TNM staging system for lung cancer, Ann Thorac Cardiovasc Surg, 15, 4
Billing, 2001, Surgical treatment of primary lung cancer with synchronous brain metastases, J Thorac Cardiovasc Surg, 122, 548, 10.1067/mtc.2001.116201
Iwasaki, 2004, Evaluation of the treatment of non–small-cell lung cancer with brain metastasis and the role of risk score as a survival predictor, Eur J Cardiothorac Surg, 26, 488, 10.1016/j.ejcts.2004.05.049
Raz, 2011, Outcomes of patients with isolated adrenal metastasis from non–small-cell lung carcinoma, Ann Thorac Surg, 92, 1788, 10.1016/j.athoracsur.2011.05.116
Tree, 2013, Stereotactic body radiotherapy for oligometastases, Lancet Oncol, 14, e28, 10.1016/S1470-2045(12)70510-7
Luketich, 1995, Successful treatment of solitary extracranial metastases from non–small-cell lung cancer, Ann Thorac Surg, 60, 1609, 10.1016/0003-4975(95)00760-1
Tanvetyanon, 2008, Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non–small-cell lung cancer: a systematic review and pooled analysis, J Clin Oncol, 26, 1142, 10.1200/JCO.2007.14.2091
Yano, 2010, Prognostic impact of local treatment against postoperative oligometastases in non–small-cell lung cancer, J Surg Oncol, 102, 852, 10.1002/jso.21750
Getman, 2004, Prognosis of patients with non–small-cell lung cancer with isolated brain metastases undergoing combined surgical treatment, Eur J Cardiothorac Surg, 25, 1107, 10.1016/j.ejcts.2004.02.021
Saitoh, 1999, Prognostic factors in surgical treatment of solitary brain metastasis after resection of non–small-cell lung cancer, Lung Cancer, 24, 99, 10.1016/S0169-5002(99)00034-3
Bonnette, 2001, Surgical management of non–small-cell lung cancer with synchronous brain metastases, Chest, 119, 1469, 10.1378/chest.119.5.1469
Congedo, 2012, Surgery for oligometastatic non–small-cell lung cancer: long-term results from a single center experience, J Thorac Cardiovasc Surg, 144, 444, 10.1016/j.jtcvs.2012.05.051
Abacioglu, 2010, Gamma knife radiosurgery in non–small-cell lung cancer patients with brain metastases: treatment results and prognostic factors, J BUON, 15, 274
Khan, 2006, Long-term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non–small-cell lung carcinoma (NSCLC), Radiother Oncol, 81, 163, 10.1016/j.radonc.2006.09.006
Chee, 2008, Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited, Arch Intern Med, 168, 1541, 10.1001/archinte.168.14.1541
Shaw, 2013, Crizotinib versus chemotherapy in advanced ALK-positive lung cancer, N Engl J Med, 368, 2385, 10.1056/NEJMoa1214886
Utley, 2010, Interpreting data from surgical follow-up studies: the role of modeling, J Thorac Oncol, 5, S200, 10.1097/JTO.0b013e3181dd0a8d
Andrews, 2004, Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial, Lancet, 363, 1665, 10.1016/S0140-6736(04)16250-8
Patchell, 1990, A randomized trial of surgery in the treatment of single metastases to the brain, N Engl J Med, 322, 494, 10.1056/NEJM199002223220802